Created in 2004 (United States), BIOVANCE own
126 sister brands
and 17477 competing brands.
The BIOVANCE brand is owned by Celgene, a company listed in New York.
BIOVANCE is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.